Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neville F Hacker

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Cancer Research|August 18, 2004
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancerZhen Zhang, Robert C Bast, Yinhua Yu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 14, 2020
Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of careCharles H Norell, John Butler, Rhonda Farrell, et al.
Breast Cancer Research : BCR|June 13, 2020
Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancerLaura A Baker, Holly Holliday, Daniel Roden, et al.
Nature Communications|September 4, 2019
The molecular origin and taxonomy of mucinous ovarian carcinomaDane Cheasley, Matthew J Wakefield, Georgina L Ryland, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Cancer Research|August 18, 2004
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancerZhen Zhang, Robert C Bast, Yinhua Yu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 14, 2020
Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of careCharles H Norell, John Butler, Rhonda Farrell, et al.
Breast Cancer Research : BCR|June 13, 2020
Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancerLaura A Baker, Holly Holliday, Daniel Roden, et al.
Nature Communications|September 4, 2019
The molecular origin and taxonomy of mucinous ovarian carcinomaDane Cheasley, Matthew J Wakefield, Georgina L Ryland, et al.
Pageof 7